Ophthalmologists perform a dilated fundus examination to diagnose retinal tears. Dilating drops widen the pupil to allow ...

To evaluate the treatment of central serous chorioretinopathy (CSC) with either subthreshold diode laser MicroPulse (SDM) or intravitreal bevacizumab (BCZ). At the end of the study, there was 12.5% ...

Laser photocoagulation is a type of eye surgery. It’s not a common way to treat wet age-related macular degeneration (AMD), but it might be the right choice for some people. Talk to your doctor about ...

Laser photocoagulation helps slow vision loss in people with wet age-related macular degeneration The laser seals leaking blood vessels beneath the macula to prevent further damage While it may cause ...

To determine the effects of argon green panretinal laser photocoagulation on retinal nerve fibre layer thickness, threshold visual fields, and Estermann full-binocular visual fields over time in ...

Please provide your email address to receive an email when new articles are posted on . The phase 3 BUTTERFLEYE trial compared aflibercept vs. laser photocoagulation in infants with retinopathy of ...

Please provide your email address to receive an email when new articles are posted on . Argon laser photocoagulation is a safe alternative to conventional surgical excision for cosmetic pinguecula ...

This story is part of a series on the current progression in Regenerative Medicine. This piece is part of a series dedicated to the eye and improvements in restoring vision. In 1999, I defined ...

The BUTTERFLEYE trial sought to determine if aflibercept, an anti–vascular endothelial growth factor (anti-VEGF) therapy, was equivalent to laser photocoagulation, the gold standard to treat ...

August 30, 2011 — The US Food and Drug Administration (FDA) has granted 510(k) clearance for a multicolor pattern scan laser photocoagulator (MC-500 Vixi, NIDEK Co, Ltd), the first pattern scan laser ...

Launched in 2005, the Vitra 532 nm laser revolutionized the principles of retinal photocoagulation. Small, handy and practical, the laser quickly won over the ophthalmological community.

Why did a 38-year-old woman with neurofibromatosis type 1 (NF1) develop choroidal Yasunari nodules in both eyes? That's what Danish clinicians had to figure out when the patient presented for a ...